{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:33:46Z","timestamp":1790645626730,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ejca.2020.09.013","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T09:05:31Z","timestamp":1602493531000},"page":"71-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Impact of prophylaxis choice on risk of pneumocystis pneumonia in children with cancer: A case-control study"],"prefix":"10.1016","volume":"140","author":[{"given":"Ashley V.","family":"Geerlinks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3761-6995","authenticated-orcid":false,"given":"Aaron","family":"Campigotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Science","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2020.09.013_bib1","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.09.013_bib2","series-title":"Red book 2015 : Report of the committee on infectious diseases","author":"Kimberlin","year":"2015"},{"key":"10.1016\/j.ejca.2020.09.013_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkw157","article-title":"ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Maertens","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ejca.2020.09.013_bib4","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1200\/JCO.18.00374","article-title":"Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2020.09.013_bib5","series-title":"Cochrane database of systematic reviews","article-title":"Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients","author":"Stern","year":"2014"},{"issue":"26","key":"10.1016\/j.ejca.2020.09.013_bib6","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM197712292972602","article-title":"Successful chemoprophylaxis for Pneumocystis carinii pneumonitis","volume":"297","author":"Hughes","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.09.013_bib7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/pbc.21287","article-title":"Intravenous pentamidine is effective as second linePneumocystis pneumonia prophylaxis in pediatric oncology patients","volume":"50","author":"Kim","year":"2008","journal-title":"Pediatr Blood Canc"},{"key":"10.1016\/j.ejca.2020.09.013_bib8","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/cncr.22562","article-title":"Prophylaxis of Pneumocystis carinii pneumonia with atovaquone in children with leukemia","volume":"109","author":"Madden","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2020.09.013_bib9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/MPH.0000000000000804","article-title":"Efficacy and safety of dapsone versus trimethoprim\/sulfamethoxazol for pneumocystis jiroveci prophylaxis in children with acute lymphoblastic leukemia with a background of ethnic neutropenia","volume":"39","author":"Nazir","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ejca.2020.09.013_bib10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1200\/JCO.1994.12.1.136","article-title":"Successful Pneumocystis carinii pneumonia prophylaxis using aerosolized pentamidine in children with acute leukemia","volume":"12","author":"Weinthal","year":"1994","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2020.09.013_bib11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199503163321101","article-title":"A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection","volume":"332","author":"Bozzette","year":"1995","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ejca.2020.09.013_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archinte.1996.00440020081010","article-title":"A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens","volume":"156","author":"Ioannidis","year":"1996","journal-title":"Arch Intern Med"},{"issue":"26","key":"10.1016\/j.ejca.2020.09.013_bib13","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJM199212243272603","article-title":"A controlled trial of aerosolized pentamidine or trimethoprim\u2013sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection","volume":"327","author":"Schneider","year":"1992","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.ejca.2020.09.013_bib14","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJM199212243272604","article-title":"A controlled trial of trimethoprim\u2013sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: AIDS Clinical Trials Group protocol 021","volume":"327","author":"Hardy","year":"1992","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.ejca.2020.09.013_bib15","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJM199305273282102","article-title":"Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection","volume":"328","author":"Girard","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.09.013_bib16","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/pbc.21202","article-title":"Pneumocystis pneumonia in children receiving chemotherapy","volume":"50","author":"Prasad","year":"2008","journal-title":"Pediatr Blood Canc"},{"key":"10.1016\/j.ejca.2020.09.013_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26453","article-title":"The use of intravenous pentamidine for the prophylaxis of Pneumocystis pneumonia in pediatric patients","author":"Kruizinga","year":"2017","journal-title":"Pediatr Blood Canc"},{"key":"10.1016\/j.ejca.2020.09.013_bib18","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1097\/MPH.0000000000000584","article-title":"Safety and effectiveness of intravenous pentamidine for prophylaxis of pneumocystis jirovecii pneumonia in pediatric hematology\/oncology patients","volume":"38","author":"Solodokin","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"issue":"17","key":"10.1016\/j.ejca.2020.09.013_bib19","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1200\/JCO.2011.38.9924","article-title":"Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children\u2019s oncology group","volume":"30","author":"Bhatia","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2020.09.013_bib20","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJM198706253162604","article-title":"Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis","volume":"316","author":"Hughes","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.09.013_bib21","first-page":"164","article-title":"Single-day trimethoprim\/sulfamethoxazole prophylaxis for pneumocystis pneumonia in children with cancer","author":"Caselli","year":"2014","journal-title":"J Pediatr"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920305190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920305190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:29:34Z","timestamp":1760732974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804920305190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":21,"alternative-id":["S0959804920305190"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2020.09.013","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of prophylaxis choice on risk of pneumocystis pneumonia in children with cancer: A case-control study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2020.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}